Katy Jeannot

4.2k total citations
73 papers, 2.4k citations indexed

About

Katy Jeannot is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Katy Jeannot has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Medicine, 32 papers in Molecular Biology and 21 papers in Pharmacology. Recurrent topics in Katy Jeannot's work include Antibiotic Resistance in Bacteria (58 papers), Bacterial biofilms and quorum sensing (28 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Katy Jeannot is often cited by papers focused on Antibiotic Resistance in Bacteria (58 papers), Bacterial biofilms and quorum sensing (28 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Katy Jeannot collaborates with scholars based in France, Germany and United States. Katy Jeannot's co-authors include Patrick Plésiat, Arnaud Bolard, Patrick Plésiat, Patrick Plésiat, Cédric Muller, Pierre‐Edouard Fournier, Patrick Plésiat, Isabelle Broutin, Ina Attrée and Sophie Loeffert and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Katy Jeannot

70 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Katy Jeannot 1.9k 1.1k 555 486 362 73 2.4k
Xiaoting Hua 1.7k 0.9× 876 0.8× 395 0.7× 709 1.5× 198 0.5× 138 2.6k
Laura Zamorano 2.3k 1.2× 1.2k 1.1× 935 1.7× 549 1.1× 244 0.7× 67 2.9k
Antonio Oliver 1.8k 0.9× 973 0.9× 655 1.2× 386 0.8× 242 0.7× 39 2.2k
Bartolomé Moyá 2.7k 1.4× 1.3k 1.2× 1.1k 1.9× 657 1.4× 377 1.0× 51 3.2k
Philip Lister 1.7k 0.9× 985 0.9× 853 1.5× 306 0.6× 221 0.6× 50 2.6k
Carla López-Causapé 1.6k 0.8× 982 0.9× 445 0.8× 281 0.6× 169 0.5× 69 2.0k
Patrick Plésiat 1.3k 0.7× 767 0.7× 363 0.7× 355 0.7× 303 0.8× 25 2.0k
Eun-Jeong Yoon 1.5k 0.8× 682 0.6× 310 0.6× 554 1.1× 173 0.5× 59 2.0k
Abiola Olumuyiwa Olaitan 1.5k 0.8× 434 0.4× 386 0.7× 523 1.1× 214 0.6× 25 1.9k
Ignasi Roca 1.6k 0.9× 768 0.7× 313 0.6× 907 1.9× 125 0.3× 57 2.2k

Countries citing papers authored by Katy Jeannot

Since Specialization
Citations

This map shows the geographic impact of Katy Jeannot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Jeannot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Jeannot more than expected).

Fields of papers citing papers by Katy Jeannot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Jeannot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Jeannot. The network helps show where Katy Jeannot may publish in the future.

Co-authorship network of co-authors of Katy Jeannot

This figure shows the co-authorship network connecting the top 25 collaborators of Katy Jeannot. A scholar is included among the top collaborators of Katy Jeannot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Jeannot. Katy Jeannot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomis-Font, María A., Salud Rodríguez-Pallares, Alejandro Beceiro, et al.. (2025). Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 69(12). e0104825–e0104825.
2.
Ize, Bérengère, Katy Jeannot, Delphine Payros, et al.. (2025). Uncovering a new family of conserved virulence factors that promote the production of host‐damaging outer membrane vesicles in Gram‐negative bacteria. Journal of Extracellular Vesicles. 14(1). e270032–e270032. 3 indexed citations
3.
Torres, Marcelo D. T., Floriana Cappiello, Katy Jeannot, et al.. (2024). Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities. Journal of Medicinal Chemistry. 67(16). 14040–14061. 9 indexed citations
4.
Job, Viviana, Maxime Bour, Mylène Robert‐Genthon, et al.. (2024). Pseudomonas aeruginosa MipA-MipB envelope proteins act as new sensors of polymyxins. mBio. 15(3). e0221123–e0221123. 6 indexed citations
5.
Fournier, Pierre‐Edouard, et al.. (2024). Evaluation of EUCAST rapid antimicrobial susceptibility test directly from positive blood culture for Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 43(10). 2061–2064.
6.
Fournier, Pierre‐Edouard, et al.. (2023). Evaluation of 5 rapid colorimetric and immunochromatographic tests for the detection of carbapenemases in Pseudomonas aeruginosa and Acinetobacter spp. isolates. European Journal of Clinical Microbiology & Infectious Diseases. 42(8). 1043–1045. 1 indexed citations
7.
8.
Apalata, Teke, et al.. (2023). Phenotypic Characterization and Prevalence of Carbapenemase-Producing Pseudomonas aeruginosa Isolates in Six Health Facilities in Cameroon. SHILAP Revista de lepidopterología. 3(1). 77–88. 10 indexed citations
9.
Desriac, Florie, Magalie Barreau, François Sichel, et al.. (2023). 6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens. International Journal of Molecular Sciences. 24(10). 8568–8568. 3 indexed citations
10.
Casanova, Magali, Hamza Olleik, Jean‐François Cavalier, et al.. (2023). Evaluation of the Efficiency of Random and Diblock Methacrylate-Based Amphiphilic Cationic Polymers against Major Bacterial Pathogens Associated with Cystic Fibrosis. Antibiotics. 12(1). 120–120. 7 indexed citations
11.
Vasseur, Virginie, et al.. (2023). Poly-L-Lysine to Fight Antibiotic Resistances of Pseudomonas aeruginosa. International Journal of Molecular Sciences. 24(3). 2851–2851. 5 indexed citations
12.
Bouiller, Kévin, Thomas W. LeBlanc, Katy Jeannot, et al.. (2020). Number, type and cost of microbiological tests during HIV Pre-Exposure Prophylaxis: The experience of a French hospital. Infectious Diseases Now. 51(4). 357–361. 1 indexed citations
13.
Hong, Zhilai, Arnaud Bolard, Caroline Giraud, et al.. (2018). Azetidine‐Containing Alkaloids Produced by a Quorum‐Sensing Regulated Nonribosomal Peptide Synthetase Pathway in Pseudomonas aeruginosa. Angewandte Chemie International Edition. 58(10). 3178–3182. 38 indexed citations
14.
Hong, Zhilai, Arnaud Bolard, Caroline Giraud, et al.. (2018). Azetidine‐Containing Alkaloids Produced by a Quorum‐Sensing Regulated Nonribosomal Peptide Synthetase Pathway in Pseudomonas aeruginosa. Angewandte Chemie. 131(10). 3210–3214. 5 indexed citations
15.
Al‐Agamy, Mohamed H., Katy Jeannot, Taghrid S. El-Mahdy, et al.. (2016). First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Microbial Drug Resistance. 23(5). 556–562. 39 indexed citations
16.
Pereyre, Sabine, Cécile Bébéar, A. Beby‐Defaux, et al.. (2016). Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases. Clinical Microbiology and Infection. 23(2). 122.e1–122.e7. 33 indexed citations
17.
Bentzmann, Sophie de, Caroline Giraud, C. Bernard, et al.. (2012). Correction: Unique Biofilm Signature, Drug Susceptibility and Decreased Virulence in Drosophila through the Pseudomonas aeruginosa Two-Component System PprAB. PLoS Pathogens. 8(12). 9 indexed citations
18.
Muller, Cédric, Patrick Plésiat, & Katy Jeannot. (2010). A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 55(3). 1211–1221. 168 indexed citations
19.
Jeannot, Katy, Sylvie Elsen, Thilo Köhler, et al.. (2008). Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. HAL (Le Centre pour la Communication Scientifique Directe). 6 indexed citations
20.
Hocquet, Didier, P. Berthelot, Micheline Roussel‐Delvallez, et al.. (2007). Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 51(10). 3531–3536. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoting Hua Breakdown of academic impact, for papers by Laura Zamorano Breakdown of academic impact, for papers by Antonio Oliver Breakdown of academic impact, for papers by Bartolomé Moyá Breakdown of academic impact, for papers by Philip Lister Breakdown of academic impact, for papers by Carla López-Causapé Breakdown of academic impact, for papers by Patrick Plésiat Breakdown of academic impact, for papers by Eun-Jeong Yoon Breakdown of academic impact, for papers by Abiola Olumuyiwa Olaitan Breakdown of academic impact, for papers by Ignasi Roca
Rankless by CCL
2026